MediLexicon Logo
MediLexicon Logo
Abbreviations        Abbrev Definitions        Dictionary        ICD9 Codes        Equipment        Hospitals        Drugs        More..
  

Useful Websites

Medical Tourism
Compare and save on surgery

Global Translations
Medical and Clinical Translation

specialistinfo.com
Details of over 40,000 UK Specialists and over 42,000 GPs

Global RPH
medical software

Doctors Lounge
Ask a Doctor and Disease Information

Health News
from Medical News Today.

MRCP 1 Revision
123 Doc medical courses for junior doctors.

CoreyNahman
pharmaceutical news daily

Hospital Search
Worldwide hospital database, search by country or keyword.

Metric Converters
The Calculator Site - unit conversion tools.
headlines news headlines   email email to a friend   printer printer friendly   newsletter sign up to newsletter  

U Of MN Researchers Turn Cord Blood Into Lung Cells

Main Category: Stem Cell Research
Also Included In: Respiratory / Asthma | Cystic Fibrosis | Pediatrics / Children's Health
Article Date: 02 Nov 2006

Researchers at the University of Minnesota have, for the first time, coaxed umbilical cord blood stem cells to differentiate into a type of lung cell.

The cord blood cells differentiated into a type of lung cell called type II alveolar cells. These cells are responsible for secreting surfactant, a substance which allows the air sacs in the lungs to remain open, allowing air to move in and out of the sacs. The cells are also responsible for helping to repair the airway after injury.

"In the future, we may be able to examine cord blood from babies who have lung diseases, such as cystic fibrosis, to do more research to understand how these diseases evolve as well as to develop better medical treatments," said David McKenna, M.D., assistant professor of lab medicine and pathology and medical director of the Clinical Cell Therapy Lab at the University of Minnesota Medical Center, Fairview.

The research paper is currently available online, and will be published in the Nov. 7, 2006, issue of the journal Cytotherapy.

Type II alveolar cells develop late in fetal development, which is why some premature babies are born with underdeveloped lungs. The cells and the air sacs as a whole continue to mature and develop through a child's first few years of life.

Now the researchers will try to better characterize the cells, so that in the future, the cells could be used as a research tool to better understand lung development and disease. The cells may also be useful as a way to test potential new drugs.

To differentiate the lung cells from the cord blood, McKenna and his team first derived the Multi-Lineage Progenitor CellTM (MLPCTM) from umbilical cord blood. This stem cell, which was first isolated and characterized by BioE®, Inc., St. Paul, is a precursor cell that can be expanded in culture, then differentiated into different types of tissue representative of all three embryonic lineages, endoderm, mesoderm and ectoderm.

In this series of experiments, McKenna and his group cultured the MLPC and differentiated it into the lung cells, an endoderm-type cell. By testing the cells that grew with various methods, they were able to find cells that exhibited key markers present in type II alveolar cells.

###

The research was funded by BioE, Inc.

Contact: Sara E. Buss
University of Minnesota

Original article posted on Medical News Today.
Articles not to be reproduced without permission of Medical News Today

Medical News Today publishes the latest health news and health videos for consumers and health professionals. It has a searchable archive of over 100,000 health news articles.





For any corrections of factual information, or to contact the editors please use our feedback form.
Send your press releases to





Forum Icon

Medical Terminology Forums

Discuss issues relating to medical abbreviations and dictionary terms in our new forum...

Visit our terminology forums









Privacy Policy   |    Disclaimer      

MediLexicon International Ltd, UK Office: +44 (0) 1625 415 347
MediLexicon International Ltd © 2009 All rights reserved.